IBD 50 Stocks To Watch: The Leading Name In This Nascent Market Nears Buy Point

IBD 50 Stocks To Watch: The Leading Name In This Nascent Market Nears Buy Point

Sitting on a 42% year to date gain, despite spending 20 weeks in consolidations, health care stock Progyny is climbing toward a buy point.